BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 37369946)

  • 1. Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics.
    Janin M; Davalos V; Esteller M
    Cancer Metastasis Rev; 2023 Dec; 42(4):1071-1112. PubMed ID: 37369946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring epitranscriptomics for crop improvement and environmental stress tolerance.
    Yang X; Patil S; Joshi S; Jamla M; Kumar V
    Plant Physiol Biochem; 2022 Jul; 183():56-71. PubMed ID: 35567875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Writers, readers and erasers of RNA modifications in cancer.
    Esteve-Puig R; Bueno-Costa A; Esteller M
    Cancer Lett; 2020 Apr; 474():127-137. PubMed ID: 31991154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
    Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenomic alterations in cancer: mechanisms and therapeutic potential.
    Gray JS; Wani SA; Campbell MJ
    Clin Sci (Lond); 2022 Apr; 136(7):473-492. PubMed ID: 35383835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epi-miRNAs: Modern mediators of methylation status in human cancers.
    Papadimitriou MA; Panoutsopoulou K; Pilala KM; Scorilas A; Avgeris M
    Wiley Interdiscip Rev RNA; 2023 Mar; 14(2):e1735. PubMed ID: 35580998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications.
    Porcellini E; Laprovitera N; Riefolo M; Ravaioli M; Garajova I; Ferracin M
    Cancer Lett; 2018 Apr; 419():84-95. PubMed ID: 29360561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.
    Biswas S; Rao CM
    Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent RNA modifications and their budding crosstalk with plant epigenetic processes.
    Bhatia G; Prall W; Sharma B; Gregory BD
    Curr Opin Plant Biol; 2022 Oct; 69():102287. PubMed ID: 35988352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitranscriptomic Code and Its Alterations in Human Disease.
    Kadumuri RV; Janga SC
    Trends Mol Med; 2018 Oct; 24(10):886-903. PubMed ID: 30120023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic and Epitranscriptomic Control in Prostate Cancer.
    López J; Añazco-Guenkova AM; Monteagudo-García Ó; Blanco S
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation.
    Kan RL; Chen J; Sallam T
    Trends Genet; 2022 Feb; 38(2):182-193. PubMed ID: 34294427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics Mechanism and Therapeutic Potential of Approved Epi-drugs in Pulmonary Hypertension Disease.
    Zhanqiang L; Huoqiang H; Dianxiang L
    Curr Top Med Chem; 2023; 23(18):1715-1726. PubMed ID: 37013430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities.
    Ge T; Gu X; Jia R; Ge S; Chai P; Zhuang A; Fan X
    Cancer Commun (Lond); 2022 Nov; 42(11):1049-1082. PubMed ID: 36266736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
    Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
    Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics: an emerging player in gastric cancer.
    Kang C; Song JJ; Lee J; Kim MY
    World J Gastroenterol; 2014 Jun; 20(21):6433-47. PubMed ID: 24914365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitranscriptomics in metabolic disease.
    Matsumura Y; Wei FY; Sakai J
    Nat Metab; 2023 Mar; 5(3):370-384. PubMed ID: 36959512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mark of disease: how mRNA modifications shape genetic and acquired pathologies.
    Destefanis E; Avşar G; Groza P; Romitelli A; Torrini S; Pir P; Conticello SG; Aguilo F; Dassi E
    RNA; 2021 Apr; 27(4):367-389. PubMed ID: 33376192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.